BioCentury
ARTICLE | Clinical News

Avinza morphine regulatory update

February 16, 2009 8:00 AM UTC

FDA said certain marketed opioid drugs will be required to have a risk evaluation and mitigation strategy (REMS). The affected products, which include 9 branded and 15 generic drugs, are formulated wi...